Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
1.
J Alzheimers Dis ; 16(2): 287-300, 2009.
Article in English | MEDLINE | ID: mdl-19221418

ABSTRACT

Most patients with Alzheimer's disease (AD) present decreased levels of melatonin, a day-night rhythm-related hormone. To investigate the role of melatonin deficiency in AD, we used constant illumination to interrupt melatonin metabolism and measured some of the AD-like alterations in rats. Concomitant with decreased serum melatonin, the rats developed spatial memory deficits, tau hyperphosphorylation at multiple sites, activation of glycogen synthase kinase-3 and protein kinase A, as well as suppression of protein phosphatase-1. Prominent oxidative damage and organelle lesions, demonstrated by increased expression of endoplasmic reticulum (ER) stress-related proteins including BiP/GRP78 and CHOP/GADD153, decreased number of rough ER and free ribosome, thinner synapses, and increased superoxide dismutase and monoamine oxidase were also observed in the light exposed rats. Simultaneous supplement of melatonin partially arrested the behavioral and molecular impairments. It is suggested that melatonin deficiency may be an upstream effector responsible for the AD-like behavioral and molecular pathologies with ER stress-involved mechanisms.


Subject(s)
Alzheimer Disease/pathology , Alzheimer Disease/prevention & control , Antioxidants/therapeutic use , Endoplasmic Reticulum/pathology , Melatonin/therapeutic use , Alzheimer Disease/blood , Alzheimer Disease/complications , Animals , Behavior, Animal , Cyclic AMP-Dependent Protein Kinases/metabolism , Disease Models, Animal , Dose-Response Relationship, Drug , Dose-Response Relationship, Radiation , Endoplasmic Reticulum/drug effects , Endoplasmic Reticulum/ultrastructure , Glycogen Synthase Kinase 3/metabolism , Hippocampus/drug effects , Hippocampus/enzymology , Hippocampus/ultrastructure , Lighting/adverse effects , Male , Maze Learning/drug effects , Maze Learning/physiology , Melatonin/blood , Microscopy, Immunoelectron/methods , Monoamine Oxidase/metabolism , Phosphoric Monoester Hydrolases/metabolism , Rats , Rats, Wistar , Reaction Time/drug effects , Reaction Time/radiation effects , Superoxide Dismutase/metabolism , tau Proteins/metabolism
2.
J Agric Food Chem ; 53(7): 2441-5, 2005 Apr 06.
Article in English | MEDLINE | ID: mdl-15796576

ABSTRACT

The procyanidins of nonedible parts of lotus (Nelumbo nucifera Gaertn.) were determined for the first time. The procyanidins of lotus seedpod were extracted with Me(2)CO/H(2)O and purified by Sephadex LH-20 column chromatography, with a purity of >98%. ESI-MS analysis showed that the main molecular weight distribution of procyanidins ranged from 291 to 1155, with M + H peak values of 291.1, 579.2, 731.2, 867.2, 1019.4, and 1155.3, respectively. This indicates that the extract contains monomers, dimers, and tetramers of procyanidins, in which the amounts of dimers are greatest, and catechin and epicatechin are the base units. (1)H NMR and (13)C NMR spectra confirmed that two to four monomers are linked through C(4)-C(8) (or C(6)) bonds. The effects of the procyanidins on lipid autoxidation, lipoxygenase activities, and free radical scavenging were also studied. The results showed that 0.1% procyanidins have a strong antioxidant activity in a soybean oil system, better than BHT at the same concentration; inhibited lipoxygenase activity by >90% at a concentration of 62.5 mug/mL, with an IC(50) value of 21.6 mug/mL; and had IC(50) inhibitory values rate to (*)OH of 10.5 mg/L and a scavenging effect on O(2)(*)(-) of 17.6 mg/L.


Subject(s)
Antioxidants/isolation & purification , Nelumbo/chemistry , Proanthocyanidins/isolation & purification , Seeds/chemistry , Antioxidants/chemistry , Antioxidants/pharmacology , Chemical Phenomena , Chemistry, Physical , Dimerization , Free Radical Scavengers , Hydroxyl Radical/chemistry , Lipid Peroxidation/drug effects , Lipoxygenase Inhibitors/pharmacology , Magnetic Resonance Spectroscopy , Proanthocyanidins/chemistry , Proanthocyanidins/pharmacology , Spectrometry, Mass, Electrospray Ionization , Superoxides/chemistry
3.
Chin Med Sci J ; 20(2): 83-7, 2005 Jun.
Article in English | MEDLINE | ID: mdl-16075743

ABSTRACT

OBJECTIVE: To investigate effect of inhibiting melatonin biosynthesis on activities of protein kinase A (PKA), glycogen synthase kinase-3 (GSK-3) and tau phosphorylation at PS214 and M4 epitopes using haloperidol, a specific inhibitor of 5-hydroxyindole-O-methyltransferase. METHODS: Brain ventricular and intraperitoneal injections were used for haloperidol administration, Western blots for tau phosphorylation, 32P-labeling for PKA and GSK-3 activity, and high performance liquid chromatograph for detection of serum melatonin levels. RESULTS: Haloperidol injection through the lateral ventricle and intraperitoneal reinforcement significantly stimulated PKA activity with a concurrent hyperphosphorylation of tau at M4 (Thr231/Ser235) and PS214 (Ser214) sites. Prior treatment of the rats using melatonin supplement for one week and reinforcement during the haloperidol administration arrested PKA activity and attenuated tau hyperphosphorylation. GSK-3 activity showed no obvious change after haloperidol injection, however, melatonin supplements and reinforcements during haloperidol infusion inactivated basal activity of GSK-3. CONCLUSION: Decreased melatonin may be involved in Alzheimer-like tau hyperphosphorylation, and overactivation of PKA may play a crucial role in this process.


Subject(s)
Cyclic AMP-Dependent Protein Kinases/metabolism , Haloperidol/pharmacology , Hippocampus/metabolism , Melatonin/biosynthesis , tau Proteins/metabolism , Animals , Epitopes , Glycogen Synthase Kinase 3/metabolism , Haloperidol/administration & dosage , Hippocampus/enzymology , Injections, Intraperitoneal , Injections, Intraventricular , Male , Melatonin/blood , Phosphorylation/drug effects , Rats , Rats, Wistar
4.
J Pineal Res ; 37(2): 71-7, 2004 Sep.
Article in English | MEDLINE | ID: mdl-15298664

ABSTRACT

We have found recently that melatonin protects SH-SY5Y neuroblastoma cells from calyculin A-induced neurofilament impairment and neurotoxicity. In the present study, we further investigated the in vivo effect of inhibiting melatonin biosynthesis on spatial memory retention and tau phosphorylation in rats and the potential underlying mechanisms by using haloperidol, a specific inhibitor of 5-hydroxyindole-O-methyltransferase, and a key enzyme in melatonin biosynthesis. We have found that injection of haloperidol into the lateral ventricle and into peritoneal cavity compromises spatial memory retention of rats and induces hyperphosphorylation of microtubule-associated protein tau at tau-1 (Ser199/Ser202) and PHF-1 (Ser396/Ser404) epitopes. At mean time, the activity of protein phosphatase-2A (PP-2A), a deficit phosphatase in the Alzheimer's disease brain and superoxide dismutase decreases with an elevated level of malondialdehyde. Supplementation with melatonin by prior injection for 1 wk and reinforcement during the haloperidol administration significantly improves memory retention deficits, arrests tau hyperphosphorylation and oxidative stress, and restores PP-2A activity. These results strongly support the involvement of decreased melatonin in Alzheimer-like spatial memory impairment and tau hyperphosphorylation, and PP-2A may play a role in mediating aberrant melatonin-induced lesions.


Subject(s)
Brain/physiology , Melatonin/biosynthesis , Memory/physiology , tau Proteins/metabolism , Animals , Blotting, Western , Brain/drug effects , Enzyme Inhibitors/administration & dosage , Haloperidol/administration & dosage , Injections, Intraventricular , Male , Maze Learning/drug effects , Maze Learning/physiology , Memory/drug effects , Phosphorylation/drug effects , Rats , Rats, Wistar
5.
J Pineal Res ; 37(1): 11-6, 2004 Aug.
Article in English | MEDLINE | ID: mdl-15230863

ABSTRACT

Hyperphosphorylation of microtubule-associated protein tau at specific sites is a recognized pathological process in Alzheimer's disease (AD), and protein kinase A (PKA) is a crucial kinase in AD-like tau hyperphosphorylation. In the present study, isoproterenol (ISO) was injected bilaterally into hippocampus of rat brain; ISO is a specific PKA activator and it induces tau hyperphosphorylation. With this system, melatonin (MT) was shown to protect against ISO-induced tau hyperphosphorylation. We found that hippocampal injection of ISO (0.02 microm) induced PKA overactivation and tau hyperphosphorylation at both paired helical filament (PHF)-1 and tau-1 sites. ISO injection also resulted in activation of superoxide dismutase (SOD) and elevation of malondialdehyde (MDA), parameters suggesting elevated oxidative stress. Preinfusion of MT intraperitoneally partially reversed ISO-induced tau hyperphosphorylation at the PHF-1 epitope (1 and 10 mg/kg continuously for 4 wk or 10 mg/kg for 1, 2 or 3 wk) and tau-1 epitope (10 mg/kg for 2 wk). Furthermore, MT (10 mg/kg for 2 wk) obviously antagonized ISO-induced PKA overactivation, as well as enhanced SOD activity and decreased the level of MDA. It is suggested from these data that ISO may induce abnormal hyperphosphorylation of tau through not only the activation of PKA but also because of the fact that it increases oxidative stress; MT may protect against ISO-induced tau hyperphosphorylation through suppression of both PKA overactivation and oxidative stress.


Subject(s)
Antioxidants/administration & dosage , Brain/metabolism , Cyclic AMP-Dependent Protein Kinases/metabolism , Isoproterenol/administration & dosage , Melatonin/administration & dosage , Sympathomimetics/administration & dosage , tau Proteins/metabolism , Alzheimer Disease/metabolism , Animals , Male , Oxidative Stress/drug effects , Phosphorylation/drug effects , Rats , Rats, Wistar
SELECTION OF CITATIONS
SEARCH DETAIL